Lineage Cell Therapeutics Statistics
Total Valuation
LCTX has a market cap or net worth of $213.04 million. The enterprise value is $178.90 million.
| Market Cap | 213.04M |
| Enterprise Value | 178.90M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, after market close.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
LCTX has 188.53 million shares outstanding. The number of shares has increased by 1.69% in one year.
| Shares Outstanding | 188.53M |
| Shares Change (YoY) | +1.69% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 4.13% |
| Owned by Institutions (%) | 44.03% |
| Float | 139.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 23.64 |
| Forward PS | 11.82 |
| PB Ratio | 3.33 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 20.00 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.14, with a Debt / Equity ratio of 0.05.
| Current Ratio | 2.14 |
| Quick Ratio | 2.02 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -31.30% and return on invested capital (ROIC) is -37.26%.
| Return on Equity (ROE) | -31.30% |
| Return on Assets (ROA) | -19.90% |
| Return on Capital (ROIC) | -37.26% |
| Revenue Per Employee | $131,544 |
| Profits Per Employee | -$315,971 |
| Employee Count | 68 |
| Asset Turnover | 0.08 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.80M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.91% in the last 52 weeks. The beta is 1.33, so LCTX's price volatility has been higher than the market average.
| Beta (1Y) | 1.33 |
| 52-Week Price Change | -15.91% |
| 50-Day Moving Average | 1.22 |
| 200-Day Moving Average | 1.20 |
| Relative Strength Index (RSI) | 40.95 |
| Average Volume (30 Days) | 965,596 |
Short Selling Information
The latest short interest is 10.58 million, so 5.61% of the outstanding shares have been sold short.
| Short Interest | 10.58M |
| Short Previous Month | 9.98M |
| Short % of Shares Out | 5.61% |
| Short % of Float | 7.58% |
| Short Ratio (days to cover) | 9.33 |
Income Statement
In the last 12 months, LCTX had revenue of $8.95 million and -$21.49 million in losses. Loss per share was -$0.12.
| Revenue | 8.95M |
| Gross Profit | 8.27M |
| Operating Income | -24.73M |
| Pretax Income | -23.29M |
| Net Income | -21.49M |
| EBITDA | -22.60M |
| EBIT | -23.29M |
| Loss Per Share | -$0.12 |
Balance Sheet
The company has $35.49 million in cash and $2.95 million in debt, giving a net cash position of $32.54 million or $0.17 per share.
| Cash & Cash Equivalents | 35.49M |
| Total Debt | 2.95M |
| Net Cash | 32.54M |
| Net Cash Per Share | $0.17 |
| Equity / Book Value | 63.42M |
| Book Value Per Share | 0.34 |
| Working Capital | 20.48M |
Cash Flow
In the last 12 months, operating cash flow was -$28.57 million and capital expenditures -$674,000, giving a free cash flow of -$29.24 million.
| Operating Cash Flow | -28.57M |
| Capital Expenditures | -674,000 |
| Free Cash Flow | -29.24M |
| FCF Per Share | -$0.17 |
Margins
Gross margin is 92.50%, with operating and profit margins of -276.50% and -240.20%.
| Gross Margin | 92.50% |
| Operating Margin | -276.50% |
| Pretax Margin | -260.36% |
| Profit Margin | -240.20% |
| EBITDA Margin | -252.62% |
| EBIT Margin | -260.36% |
| FCF Margin | -326.89% |
Dividends & Yields
LCTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -1.69% |
| Shareholder Yield | -1.69% |
| Earnings Yield | -10.16% |
| FCF Yield | -13.83% |
Analyst Forecast
The average price target for LCTX is $6.50, which is 472.69% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.50 |
| Price Target Difference | 472.69% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 81.43% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 31, 1997. It was a forward split with a ratio of 3:1.
| Last Split Date | Oct 31, 1997 |
| Split Type | Forward |
| Split Ratio | 3:1 |
Scores
LCTX has an Altman Z-Score of -2.51 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.51 |
| Piotroski F-Score | 1 |